Copyright Reports & Markets. All rights reserved.

Global T-Cell Therapy Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global T-Cell Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 CAR T Cell Therapy
    • 1.2.3 TCR Therapy
    • 1.2.4 TIL Therapy
  • 1.3 Market by Application
    • 1.3.1 Global T-Cell Therapy Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Hospitals
    • 1.3.3 Clinics & Ambulatory Centers
    • 1.3.4 Cancer Research Institutes
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global T-Cell Therapy Market Perspective (2016-2027)
  • 2.2 T-Cell Therapy Growth Trends by Regions
    • 2.2.1 T-Cell Therapy Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 T-Cell Therapy Historic Market Share by Regions (2016-2021)
    • 2.2.3 T-Cell Therapy Forecasted Market Size by Regions (2022-2027)
  • 2.3 T-Cell Therapy Industry Dynamic
    • 2.3.1 T-Cell Therapy Market Trends
    • 2.3.2 T-Cell Therapy Market Drivers
    • 2.3.3 T-Cell Therapy Market Challenges
    • 2.3.4 T-Cell Therapy Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top T-Cell Therapy Players by Revenue
    • 3.1.1 Global Top T-Cell Therapy Players by Revenue (2016-2021)
    • 3.1.2 Global T-Cell Therapy Revenue Market Share by Players (2016-2021)
  • 3.2 Global T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by T-Cell Therapy Revenue
  • 3.4 Global T-Cell Therapy Market Concentration Ratio
    • 3.4.1 Global T-Cell Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by T-Cell Therapy Revenue in 2020
  • 3.5 T-Cell Therapy Key Players Head office and Area Served
  • 3.6 Key Players T-Cell Therapy Product Solution and Service
  • 3.7 Date of Enter into T-Cell Therapy Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 T-Cell Therapy Breakdown Data by Type

  • 4.1 Global T-Cell Therapy Historic Market Size by Type (2016-2021)
  • 4.2 Global T-Cell Therapy Forecasted Market Size by Type (2022-2027)

5 T-Cell Therapy Breakdown Data by Application

  • 5.1 Global T-Cell Therapy Historic Market Size by Application (2016-2021)
  • 5.2 Global T-Cell Therapy Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America T-Cell Therapy Market Size (2016-2027)
  • 6.2 North America T-Cell Therapy Market Size by Type
    • 6.2.1 North America T-Cell Therapy Market Size by Type (2016-2021)
    • 6.2.2 North America T-Cell Therapy Market Size by Type (2022-2027)
    • 6.2.3 North America T-Cell Therapy Market Size by Type (2016-2027)
  • 6.3 North America T-Cell Therapy Market Size by Application
    • 6.3.1 North America T-Cell Therapy Market Size by Application (2016-2021)
    • 6.3.2 North America T-Cell Therapy Market Size by Application (2022-2027)
    • 6.3.3 North America T-Cell Therapy Market Size by Application (2016-2027)
  • 6.4 North America T-Cell Therapy Market Size by Country
    • 6.4.1 North America T-Cell Therapy Market Size by Country (2016-2021)
    • 6.4.2 North America T-Cell Therapy Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe T-Cell Therapy Market Size (2016-2027)
  • 7.2 Europe T-Cell Therapy Market Size by Type
    • 7.2.1 Europe T-Cell Therapy Market Size by Type (2016-2021)
    • 7.2.2 Europe T-Cell Therapy Market Size by Type (2022-2027)
    • 7.2.3 Europe T-Cell Therapy Market Size by Type (2016-2027)
  • 7.3 Europe T-Cell Therapy Market Size by Application
    • 7.3.1 Europe T-Cell Therapy Market Size by Application (2016-2021)
    • 7.3.2 Europe T-Cell Therapy Market Size by Application (2022-2027)
    • 7.3.3 Europe T-Cell Therapy Market Size by Application (2016-2027)
  • 7.4 Europe T-Cell Therapy Market Size by Country
    • 7.4.1 Europe T-Cell Therapy Market Size by Country (2016-2021)
    • 7.4.2 Europe T-Cell Therapy Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific T-Cell Therapy Market Size (2016-2027)
  • 8.2 Asia-Pacific T-Cell Therapy Market Size by Type
    • 8.2.1 Asia-Pacific T-Cell Therapy Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific T-Cell Therapy Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific T-Cell Therapy Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific T-Cell Therapy Market Size by Application
    • 8.3.1 Asia-Pacific T-Cell Therapy Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific T-Cell Therapy Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific T-Cell Therapy Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific T-Cell Therapy Market Size by Region
    • 8.4.1 Asia-Pacific T-Cell Therapy Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific T-Cell Therapy Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America T-Cell Therapy Market Size (2016-2027)
  • 9.2 Latin America T-Cell Therapy Market Size by Type
    • 9.2.1 Latin America T-Cell Therapy Market Size by Type (2016-2021)
    • 9.2.2 Latin America T-Cell Therapy Market Size by Type (2022-2027)
    • 9.2.3 Latin America T-Cell Therapy Market Size by Type (2016-2027)
  • 9.3 Latin America T-Cell Therapy Market Size by Application
    • 9.3.1 Latin America T-Cell Therapy Market Size by Application (2016-2021)
    • 9.3.2 Latin America T-Cell Therapy Market Size by Application (2022-2027)
    • 9.3.3 Latin America T-Cell Therapy Market Size by Application (2016-2027)
  • 9.4 Latin America T-Cell Therapy Market Size by Country
    • 9.4.1 Latin America T-Cell Therapy Market Size by Country (2016-2021)
    • 9.4.2 Latin America T-Cell Therapy Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa T-Cell Therapy Market Size (2016-2027)
  • 10.2 Middle East & Africa T-Cell Therapy Market Size by Type
    • 10.2.1 Middle East & Africa T-Cell Therapy Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa T-Cell Therapy Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa T-Cell Therapy Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa T-Cell Therapy Market Size by Application
    • 10.3.1 Middle East & Africa T-Cell Therapy Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa T-Cell Therapy Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa T-Cell Therapy Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa T-Cell Therapy Market Size by Country
    • 10.4.1 Middle East & Africa T-Cell Therapy Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa T-Cell Therapy Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Gilead Sciences, Inc.
    • 11.1.1 Gilead Sciences, Inc. Company Details
    • 11.1.2 Gilead Sciences, Inc. Business Overview
    • 11.1.3 Gilead Sciences, Inc. T-Cell Therapy Introduction
    • 11.1.4 Gilead Sciences, Inc. Revenue in T-Cell Therapy Business (2016-2021)
    • 11.1.5 Gilead Sciences, Inc. Recent Development
  • 11.2 Sorrento Therapeutics
    • 11.2.1 Sorrento Therapeutics Company Details
    • 11.2.2 Sorrento Therapeutics Business Overview
    • 11.2.3 Sorrento Therapeutics T-Cell Therapy Introduction
    • 11.2.4 Sorrento Therapeutics Revenue in T-Cell Therapy Business (2016-2021)
    • 11.2.5 Sorrento Therapeutics Recent Development
  • 11.3 Fate Therapeutics Inc.
    • 11.3.1 Fate Therapeutics Inc. Company Details
    • 11.3.2 Fate Therapeutics Inc. Business Overview
    • 11.3.3 Fate Therapeutics Inc. T-Cell Therapy Introduction
    • 11.3.4 Fate Therapeutics Inc. Revenue in T-Cell Therapy Business (2016-2021)
    • 11.3.5 Fate Therapeutics Inc. Recent Development
  • 11.4 Novartis International AG
    • 11.4.1 Novartis International AG Company Details
    • 11.4.2 Novartis International AG Business Overview
    • 11.4.3 Novartis International AG T-Cell Therapy Introduction
    • 11.4.4 Novartis International AG Revenue in T-Cell Therapy Business (2016-2021)
    • 11.4.5 Novartis International AG Recent Development
  • 11.5 AbbVie Inc.
    • 11.5.1 AbbVie Inc. Company Details
    • 11.5.2 AbbVie Inc. Business Overview
    • 11.5.3 AbbVie Inc. T-Cell Therapy Introduction
    • 11.5.4 AbbVie Inc. Revenue in T-Cell Therapy Business (2016-2021)
    • 11.5.5 AbbVie Inc. Recent Development
  • 11.6 Adaptimmune Therapeutics PLC
    • 11.6.1 Adaptimmune Therapeutics PLC Company Details
    • 11.6.2 Adaptimmune Therapeutics PLC Business Overview
    • 11.6.3 Adaptimmune Therapeutics PLC T-Cell Therapy Introduction
    • 11.6.4 Adaptimmune Therapeutics PLC Revenue in T-Cell Therapy Business (2016-2021)
    • 11.6.5 Adaptimmune Therapeutics PLC Recent Development
  • 11.7 Bluebird Bio
    • 11.7.1 Bluebird Bio Company Details
    • 11.7.2 Bluebird Bio Business Overview
    • 11.7.3 Bluebird Bio T-Cell Therapy Introduction
    • 11.7.4 Bluebird Bio Revenue in T-Cell Therapy Business (2016-2021)
    • 11.7.5 Bluebird Bio Recent Development
  • 11.8 TCR2 Therapeutics, Inc.
    • 11.8.1 TCR2 Therapeutics, Inc. Company Details
    • 11.8.2 TCR2 Therapeutics, Inc. Business Overview
    • 11.8.3 TCR2 Therapeutics, Inc. T-Cell Therapy Introduction
    • 11.8.4 TCR2 Therapeutics, Inc. Revenue in T-Cell Therapy Business (2016-2021)
    • 11.8.5 TCR2 Therapeutics, Inc. Recent Development
  • 11.9 Pfizer Inc.
    • 11.9.1 Pfizer Inc. Company Details
    • 11.9.2 Pfizer Inc. Business Overview
    • 11.9.3 Pfizer Inc. T-Cell Therapy Introduction
    • 11.9.4 Pfizer Inc. Revenue in T-Cell Therapy Business (2016-2021)
    • 11.9.5 Pfizer Inc. Recent Development
  • 11.10 DiaCarta, Inc.
    • 11.10.1 DiaCarta, Inc. Company Details
    • 11.10.2 DiaCarta, Inc. Business Overview
    • 11.10.3 DiaCarta, Inc. T-Cell Therapy Introduction
    • 11.10.4 DiaCarta, Inc. Revenue in T-Cell Therapy Business (2016-2021)
    • 11.10.5 DiaCarta, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global T-Cell Therapy Scope and Market Size
    T-Cell Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global T-Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    CAR T Cell Therapy
    TCR Therapy
    TIL Therapy

    Segment by Application
    Hospitals
    Clinics & Ambulatory Centers
    Cancer Research Institutes
    Others

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Gilead Sciences, Inc.
    Sorrento Therapeutics
    Fate Therapeutics Inc.
    Novartis International AG
    AbbVie Inc.
    Adaptimmune Therapeutics PLC
    Bluebird Bio
    TCR2 Therapeutics, Inc.
    Pfizer Inc.
    DiaCarta, Inc.

    Buy now